William J.E. Frye

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Katie E. Hebron, Xiaolin Wan, Jacob S. Roth et al. · Clinical Cancer Research · 2022 · 20 citations · Full text

Progress in characterizing ABC multidrug transporters in zebrafish

Joanna R. Thomas, William J.E. Frye, Robert W. Robey et al. · Drug Resistance Updates · 2023 · 20 citations · Full text

The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers

William J.E. Frye, Lyn M. Huff, José M. González Dalmasy et al. · Cancer Drug Resistance · 2023 · 19 citations · Full text

The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors

Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet et al. · Molecular Cancer Therapeutics · 2023 · 14 citations · Full text